|
| |
ANKRD30A
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 18041742 |
We identified estrogen-response element (ERE)-like sequences nearby the NY-BR-1 promoter region, suggesting that NY-BR-1 expression might be regulated through estrogen receptors. |
| 17536312 |
testing demonstrates NY-BR-1 in a mostly focal fashion in the epithelia of ducts and acini of the mammary gland. In tumors, homogenous staining can be seen in almost all ductal carcinomas in situ and/or the intraductal component of invasive carcinomas. |
| 16335914 |
In this study we extended the expression analysis to various other normal and tumor tissues and found inconsistent expression of NY-BR-1 in normal prostate, but consistent NY-BR-1 mRNA expression in 32% of prostate cancers, but not in other tumor types |
| 16675566 |
NY-BR-1 is a differentiation antigen of the breast, which is present in normal and tumorous mammary epithelium. |
| 17330232 |
The strong expression of NY-BR-1 in breast tumors, its cytoplasmic and membrane localization and accessibility to an ectopically applied antibody now suggest to pursue NY-BR-1 as a potential target for antibody-based therapies in breast cancer patients. |
ANKRD30A results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for ANKRD30A,
or search for ANKRD30A on BioPortfolio's antibody search engine.
This page has been viewed 370 times
Recent Search Terms used to find this page: ankrd metastasis | NY-BR-1 ankyrin | Ankyrin repeat domain containing protein 30A | ankyrin and breast cancer | ankyrin repeat domain 30A | ankrd30a | Ankrd | ANKRD30A | ANKRD30A staining | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
